VIA
GILD icon

Vantage Investment Advisors’s Gilead Sciences GILD Stock Holding History

Vantage Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$249K Sell
3,227
-12
-0.4% -$906 0.05% 135
2018
Q2 		$229K Sell
3,239
-302
-9% -$21.3K 0.06% 137
2018
Q1 		$267K Hold
3,541
– – 0.07% 125
2017
Q4 		$254K Sell
3,541
-78
-2% -$5.92K 0.06% 136
2017
Q3 		$293K Sell
3,619
-318
-8% -$24.3K 0.08% 119
2017
Q2 		$264K Buy
3,937
+236
+6% +$15.7K 0.08% 120
2017
Q1 		$251K Sell
3,701
-245
-6% -$17.2K 0.08% 118
2016
Q4 		$283K Sell
3,946
-23,407
-86% -$1.74M 0.11% 106
2016
Q3 		$2.16M Buy
27,353
+198
+0.7% +$16.1K 0.96% 36
2016
Q2 		$2.26M Buy
27,155
+50
+0.2% +$4.44K 0.95% 32
2016
Q1 		$2.49M Buy
27,105
+4,857
+22% +$438K 1.1% 29
2015
Q4 		$2.25M Buy
22,248
+3,447
+18% +$359K 1.13% 28
2015
Q3 		$1.85M Buy
18,801
+3,114
+20% +$346K 1.04% 30
2015
Q2 		$1.84M Sell
15,687
-10,300
-40% -$1.13M 1.01% 28
2015
Q1 		$2.55M Buy
25,987
+13,168
+103% +$1.34M 0.72% 40
2014
Q4 		$1.21M Buy
12,819
+1,919
+18% +$198K 0.68% 39
2014
Q3 		$1.16M Buy
10,900
+5,899
+118% +$578K 0.7% 39
2014
Q2 		$415K Buy
5,001
+1,535
+44% +$119K 0.25% 68
2014
Q1 		$246K Buy
3,466
+690
+25% +$54.1K 0.16% 93
2013
Q4 		$208K Buy
+2,776
New +$193K 0.14% 101

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vantage Investment Advisors's GILD Position: Q3 2018 in Review

Vantage Investment Advisors reduced its Gilead Sciences (GILD) stake by 0.37% in Q3 2018, selling an estimated $906 and leaving 3,227 shares worth $249K. The position accounts for 0.05% of the portfolio, ranked #135.

Vantage Investment Advisors first reported a position in GILD in Q4 2013 and has held it in 20 quarters since. The position peaked at $2.55M in Q1 2015. 1,528 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

  • Vantage Investment Advisors held 3,227 shares of Gilead Sciences worth $249K as of Q3 2018.
  • Vantage Investment Advisors sold 12 Gilead Sciences shares in Q3 2018, an estimated $906.
  • Gilead Sciences made up 0.05% of Vantage Investment Advisors's portfolio in Q3 2018, its #135 holding.
  • Vantage Investment Advisors first reported a position in Gilead Sciences in Q4 2013 and has held it in 20 quarters since.
  • Vantage Investment Advisors's Gilead Sciences position peaked at $2.55M in Q1 2015.
  • 1,528 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.